We are live on ! Find out more
C

Chescapmanager Portfolio holdings

AUM $1.17B
1-Year Est. Return 42.44%
This Fund
S&P 500
This Quarter Est. Return
+17.04%
1 Year Est. Return
+42.44%
3 Year Est. Return
+202.08%
5 Year Est. Return
+174.76%
10 Year Est. Return
–
AUM
$643M
AUM Growth
+$7.21M
Cap. Flow
+$3.64M
Cap. Flow %
0.57%
Top 10 Hldgs %
57.89%
Holding
45
New
2
Increased
8
Reduced
4
Closed
5

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$22.3M
2
KBR icon
KBR
KBR
+$12.4M
3
SNOW icon
Snowflake
SNOW
+$3.25M
4
TVRD
Tvardi Therapeutics
TVRD
+$1.89M
5
GRAB icon
Grab
GRAB
+$700K

Top Sells

Rank Stock Value
1
EXPE icon
Expedia Group
EXPE
+$15.4M
2
TGT icon
Target
TGT
+$10.4M
3
TBPH icon
Theravance Biopharma
TBPH
+$3.7M
4
DAL icon
Delta Air Lines
DAL
+$1.11M
5
BX icon
Blackstone
BX
+$878K

Sector Composition

Rank Sector Weight
1 Miscellaneous 35.91%
2 Technology 20.48%
3 Industrials 17.03%
4 Consumer Discretionary 8.78%
5 Communication Services 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
U icon
26
Unity
U
$18.4B
$7.47M 1.16%
172,099
– –
LAZR
27
CALL
DELISTED
Luminar Technologies
LAZR
$6.54M 1.02%
63,333
– –
SLB icon
28
CALL
SLB Ltd
SLB
$77.3B
$6.14M 0.95%
125,000
– –
OWL icon
29
Blue Owl Capital
OWL
$6.81B
$5.4M 0.84%
463,251
+56,152
+14% +$604K
RIVN icon
30
Rivian
RIVN
$22.3B
$5.39M 0.84%
323,632
– –
GRAB icon
31
Grab
GRAB
$11.5B
$5.23M 0.81%
1,525,138
+225,000
+17% +$700K
TVRD
32
Tvardi Therapeutics
TVRD
$21.6M
$4.69M 0.73%
45,988
+13,755
+43% +$1.89M
PRDS
33
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$3.03M 0.47%
1,672,379
+500
+0% +$914
TBPH icon
34
Theravance Biopharma
TBPH
$885M
$2.97M 0.46%
287,333
-335,405
-54% -$3.7M
DAL icon
35
Delta Air Lines
DAL
$52.2B
$2.38M 0.37%
50,000
-30,000
-38% -$1.11M
DNA icon
36
Ginkgo Bioworks
DNA
$528M
$815K 0.13%
10,957
– –
KROS icon
37
Keros Therapeutics
KROS
$225M
$406K 0.06%
10,105
– –
GRABW icon
38
Grab Holdings Warrant
GRABW
$780K
$44.3K 0.01%
100,000
– –
DNA.WS
39
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$27.1K ﹤0.01%
103,521
– –
BX icon
40
Blackstone
BX
$94.1B
– –
-10,000
Closed -$878K
EXPE icon
41
Expedia Group
EXPE
$34.2B
– –
-159,000
Closed -$15.4M
TGT icon
42
Target
TGT
$72.6B
– –
-62,590
Closed -$10.4M
ATVI
43
CALL
DELISTED
Activision Blizzard
ATVI
– –
-646,400
Closed -$55.3M
DISH
44
CALL
DELISTED
DISH Network Corp.
DISH
– –
-500,000
Closed -$4.67M
1
2

Similar funds

WP
Waycross Partners Louisville, Kentucky $1.17B AUM 20.04% 1-Year Est. Return
TA
Townsend & Associates Westminster, Colorado $1.17B AUM 20.72% 1-Year Est. Return
TWM
Tanglewood Wealth Management Houston, Texas $1.18B AUM 21.17% 1-Year Est. Return
CF
Clarity Financial Houston, Texas $1.18B AUM 16.13% 1-Year Est. Return
KCM
Knighthead Capital Management New York $1.18B AUM 54.89% 1-Year Est. Return
TPI
Trust Point Inc La Crosse, Wisconsin $1.18B AUM 26.72% 1-Year Est. Return
ANBT
American National Bank & Trust Wichita Falls, Texas $1.17B AUM 36.33% 1-Year Est. Return
KBFS
Kohmann Bosshard Financial Services Fairlawn, Ohio $1.18B AUM 16.34% 1-Year Est. Return

Chescapmanager's Q2 2023 Portfolio in Review

As of Q2 2023, Chescapmanager held 45 positions worth $643M, up 1.1% from $636M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Chescapmanager's Q2 2023 filing shows 2 new, 8 increased, 4 reduced and 5 closed positions. Its largest new stake was KBR: 207,174 shares worth $13.5M. The largest sale was Expedia Group, an estimated $15.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 36% of assets, down from 45% a quarter earlier, followed by Technology and Industrials.

  • Chescapmanager's largest Q2 2023 buy was KBR: 207,174 shares worth $13.5M.
  • Chescapmanager added most to Activision Blizzard in Q2 2023, an estimated $22.3M increase.
  • Chescapmanager's biggest Q2 2023 reduction was Theravance Biopharma, cutting an estimated $3.7M.
  • Chescapmanager fully exited Expedia Group in Q2 2023, selling an estimated $15.4M.
  • Chescapmanager's ten largest holdings make up 58% of its $643M portfolio in Q2 2023.
  • Chescapmanager opened 2 new positions and closed 5 in Q2 2023.
  • Chescapmanager's portfolio value rose 1.1% quarter-over-quarter to $643M.

Based on Chescapmanager's 13F filing for Q2 2023, filed 14 Aug 2023.